Clinical traits of LRRK2-associated Parkinson's disease in Ireland:: A link between familial and idiopathic PD

被引:32
作者
Gosal, D
Ross, OA
Wiley, J
Irvine, GB
Johnston, JA
Toft, M
Mata, IF
Kachergus, J
Hulihan, M
Taylor, JP
Lincoln, SJ
Farrer, MJ
Lynch, T
Gibson, JM
机构
[1] Mater Misericordiae Hosp, Dept Neurol, Dublin 7, Ireland
[2] Univ Coll Dublin, Dublin 2, Ireland
[3] Queens Univ Belfast, Sch Biol & Biochem, Belfast, Antrim, North Ireland
[4] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
[5] Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland
关键词
LRRK2; G2019S and Parkinson's disease;
D O I
10.1016/j.parkreldis.2005.05.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The role of genetics in parkinsonism has been confirmed over the last decade with the identification of genetic variation in seven genes, which are causative in familial forms of the disorder. A number of pathogenic mutations have been identified in the latest gene LRRK2, with a Gly2019Ser amino acid substitution identified in two siblings and one patient with idiopathic Parkinson's disease from Ireland. The clinical features resemble the idiopathic variant with a tremor predominant clinical picture shared by the siblings, slow progression of symptoms, and no observation of cognitive disturbance in all. The family and the sporadic individual were apparently not related and originated from different regions of Ireland, although haplotype analysis does suggest they share a common founder. The influence of the G2019S substitution on protein function and disease phenotype has yet to be fully resolved, but its elucidation will undoubtedly further our understanding of the mechanisms underlying Parkinson's disease. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:349 / 352
页数:4
相关论文
共 13 条
[1]  
Di Fonzo A, 2005, LANCET, V365, P412
[2]   An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family [J].
Funayama, M ;
Hasegawa, K ;
Ohta, E ;
Kawashima, N ;
Komiyama, M ;
Kowa, H ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2005, 57 (06) :918-921
[3]   A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1 [J].
Funayama, M ;
Hasegawa, K ;
Kowa, H ;
Saito, M ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2002, 51 (03) :296-301
[4]   Diagnostic criteria for Parkinson disease [J].
Gelb, DJ ;
Oliver, E ;
Gilman, S .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :33-39
[5]   Common LRRK2 mutation in idiopathic Parkinson's disease [J].
Gilks, WP ;
Abou-Sleiman, PM ;
Gandhi, S ;
Jain, S ;
Singleton, A ;
Lees, AJ ;
Shaw, K ;
Bhatia, KP ;
Bonifati, V ;
Quinn, NP ;
Lynch, J ;
Healy, DG ;
Holton, JL ;
Revesz, T ;
Wood, NW .
LANCET, 2005, 365 (9457) :415-416
[6]  
KACHERGUS J, IN PRESS AM J HUM GE, V76
[7]   Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells [J].
Mathiasen, JR ;
McKenna, BAW ;
Saporito, MS ;
Ghadge, GD ;
Roos, RP ;
Holskin, BP ;
Wu, ZL ;
Trusko, SP ;
Connors, TC ;
Maroney, AC ;
Thomas, BA ;
Thomas, JC ;
Bozyczko-Coyne, D .
BRAIN RESEARCH, 2004, 1003 (1-2) :86-97
[8]   Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease [J].
Nichols, WC ;
Pankratz, N ;
Hernandez, D ;
Paisán-Ruíz, C ;
Jain, S ;
Halter, CA ;
Michaels, VE ;
Reed, T ;
Rudolph, A ;
Shults, CW ;
Singleton, A ;
Foroud, T .
LANCET, 2005, 365 (9457) :410-412
[9]   Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease [J].
Paisán-Ruíz, C ;
Jain, S ;
Evans, EW ;
Gilks, WP ;
Simón, J ;
van der Brug, M ;
de Munain, AL ;
Aparicio, S ;
Gil, AM ;
Khan, N ;
Johnson, J ;
Martinez, JR ;
Nicholl, D ;
Carrera, IM ;
Pena, AS ;
de Silva, R ;
Lees, A ;
Martí-Massó, JF ;
Pérez-Tur, J ;
Wood, NW ;
Singleton, AB .
NEURON, 2004, 44 (04) :595-600
[10]  
Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421